The associations of body mass index, C‐peptide and metabolic status in Chinese Type 2 diabetic patients
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background Chinese Type 2 diabetic subjects are generally less obese than their Caucasian counterparts. We hypothesized that lean and obese Chinese Type 2 diabetic subjects have different metabolic and insulin secretory profiles. We compared the clinical features, C peptide and metabolic status between lean/normal weight and obese diabetic subjects. Study design We conducted a cross‐sectional study on 521 consecutive diabetic subjects newly referred to a Diabetes Clinic in 1996. The subjects were categorized into underweight (< 18.5 kg/m 2), normal weight (18.5–23 kg/m 2) and overweight (≥ 23 kg/m 2) according to the re‐defined WHO criterion for obesity in Asia Pacific Region. Metabolic and anthropometric parameters were compared between groups with different levels of obesity. Results In this cohort, 5.8, 30.6 and 63.7% of subjects were underweight, normal weight and overweight, respectively, using the ‘Asian’ criteria. Of these 521 subjects, 20% had fasting C‐peptide less than 0.2 nmol/l, suggesting insulin deficiency. Fasting C‐peptide showed linear increasing trend (P < 0.001) while HbA 1c showed decreasing trend (P = 0.001) with BMI after adjustment for duration of disease. There were more subjects in the underweight group who were treated with insulin (41.3% vs. 13.9 and 8.2%, P < 0.001). Although homeostasis model assessment was similar amongst the three groups, systolic (P = 0.006) and diastolic blood pressure (P < 0.001) and triglyceride (P < 0.001) showed increasing, while HDL‐C (P < 0.001) showed decreasing, trends across different BMI groups. The underweight patients had the lowest C‐peptide and highest HbA 1c while overweight patients had the highest C‐peptide, blood pressure, triglyceride but lowest HbA 1c levels. Conclusion In Chinese Type 2 diabetic patients, lean subjects had predominant insulin deficiency and obese subjects had features of metabolic syndrome. Clinicians should have low threshold to initiate insulin therapy in lean Type 2 diabetic patients with suboptimal glycaemic control. In obese diabetic patients, aggressive control of multiple cardiovascular risks is of particular importance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Emoto, M., Nishizawa, Y., Maekawa, K., Hiura, Y., Kanda, H., Kawagishi, T., Shoji, T., Okuno, Y., & Morii, H. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.818 · Cited by 457
Insulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM?
Taylor, S. I., Accili, D., & Imai, Y. (1994) · Diabetes · doi:10.2337/diab.43.6.735 · Cited by 289
Changes in BMI and Weight Before and After the Development of Type 2 Diabetes
Looker, H. C., Knowler, W. C., & Hanson, R. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1917 · Cited by 136
Cited by
Diabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology
Chan, J. C. N., Malik, V., Jia, W., Kadowaki, T., Yajnik, C. S., Yoon, K.-H., & Hu, F. B. (2009) · JAMA · doi:10.1001/jama.2009.726 · Cited by 1,997
Self-citationMa, R. C. W., & Chan, J. C. N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12098 · Cited by 827
Self-citationChetoui, A., Kaoutar, K., Elmoussaoui, S., Boutahar, K., El Kardoudi, A., Chigr, F., & Najimi, M. (2022) · International Health · doi:10.1093/inthealth/ihz107 · Cited by 50
Ning, G., Bandgar, T., Hehnke, U., Lee, J., & Chan, J. C. N. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0595-7 · Cited by 13
“Early age of diagnosis and therefore long disease duration as well as high risk for renal dysfunction in Asian T2D patients may have implications for the selection of antidiabetes drugs [3, 5, 6, 19, 20].”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Chan, W. B., Tong, P. C. Y., Chow, C. C., So, W. Y., Ng, M. C. Y., Ma, R. C. W., Osaki, R., Cockram, C. S., & Chan, J. C. N.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2004-03-22
- Volume
- 21
- Issue
- 4
- Pages
- 349-353
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2046505026
- Cited by
- 86
- References
- 4
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The associations of body mass index, C‐peptide and metabolic status in Chinese Type 2 diabetic patients. https://app.cochat.ai/papers/10.1111/j.1464-5491.2004.01158.x
- The paper
- Chan, W. B., Tong, P. C. Y., Chow, C. C., So, W. Y., Ng, M. C. Y., Ma, R. C. W., Osaki, R., Cockram, C. S., & Chan, J. C. N. (2004). The associations of body mass index, C‐peptide and metabolic status in Chinese Type 2 diabetic patients. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2004.01158.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.